Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Embargament

Document embargat fins el 2028-05-01

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

Llicència de publicació

cc-by-nc-nd (c) Elsevier, 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/231146

Quality-by-design as the pharmaceutical innovation paradigm: mapping the field and proposing a conceptual framework

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Quality management (QM) and innovation practices are essential for business competitiveness, yet they often conflict when striving for radical advancements within complex innovation ecosystems. Amid this debate, the concept of Quality-by-Design (QbD) remains underexplored in management literature, despite its extensive development in technical fields. Taking the case of QbD in the pharmaceutical sector, this study aims at researching into its relationship with innovation, considering the interactions within the innovation ecosystem. We perform a bibliometric study, a selective content analysis combined with an assessment of the regulatory framework and relevant examples from the industry.

Citació

Citació

HERNÁNDEZ VIVANCO, Alfonso Antonio, et al. Quality-by-design as the pharmaceutical innovation paradigm: mapping the field and proposing a conceptual framework. Technological Forecasting and Social Change. 2025. Vol. 217. ISSN 0040-1625. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/231146

Exportar metadades

JSON - METS

Compartir registre